BRAFV600E mutation: A promising target in colorectal neuroendocrine carcinoma

International Journal of Cancer. Journal International Du Cancer
Levent DizdarAndreas Krieg

Abstract

To determine the role of BRAFV600E mutation and MAPK signaling as well as the effects of BRAF and MEK directed therapy in gastroenteropancreatic neuroendocrine neoplasia (GEP-NEN), with a focus on highly aggressive gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC). Using Sanger sequencing of BRAF exon 15 we determined the frequency of BRAFV600E mutations in 71 primary GEP-NENs. MEK phosphorylation was examined by immunohistochemistry in corresponding tissue samples. To evaluate the biological relevance of BRAFV600E mutation and MAPK signaling in GEP-NECs, effects of a pharmacological BRAF and MEK inhibition were analyzed in NEC cell lines both in vitro and in vivo. BRAFV600E mutation was detected in 9.9% of all GEP-NENs. Interestingly, only NECs of the colon harbored BRAFV600E mutations, leading to a mutation frequency of 46.7% in this subgroup of patients. In addition, a BRAFV600E mutation was significantly associated with high levels of MEK phosphorylation (pMEK) and advanced tumor stages. Pharmacological inhibition of BRAF and MEK abrogated NEC cell growth, inducing G1 cell cycle arrest and apoptosis only in BRAFV600E mutated cells. BRAF inhibitor dabrafenib and MEK inhibitor trametinib prevented growth of BRAFV600E ...Continue Reading

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Claudia WellbrockRichard Marais
Aug 18, 2005·British Journal of Cancer·L M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Oct 18, 2005·Nature Reviews. Molecular Cell Biology·Walter Kolch
May 15, 2007·Oncogene·A S DhillonW Kolch
Jun 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C YaoDouglas B Evans
Jul 17, 2010·International Journal of Cancer. Journal International Du Cancer·Jeanne TieJayesh Desai
Jul 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Eric W JosephNeal Rosen
Jan 12, 2011·Nature Biotechnology·James T RobinsonJill P Mesirov
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Ben LawrenceIrvin M Modlin
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Libero SantarpiaAdel K El-Naggar
Apr 21, 2012·Briefings in Bioinformatics·Helga ThorvaldsdóttirJill P Mesirov
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Sep 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H SorbyeU Knigge
Nov 2, 2012·European Journal of Gastroenterology & Hepatology·Raymond KarkoucheJean-François Emile
Mar 16, 2013·Thyroid : Official Journal of the American Thyroid Association·Kevin B KimSteven I Sherman
May 10, 2013·Frontiers in Genetics·Clare J StonesBruce C Baguley
Aug 7, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo A AsciertoUwe Trefzer
Mar 14, 2013·ACS Medicinal Chemistry Letters·Tara R RheaultDavid E Uehling
Jun 25, 2014·Nature Reviews. Cancer·Matthew HolderfieldMartin McMahon
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertDirk Schadendorf
Sep 10, 2015·The New England Journal of Medicine·Enrico TiacciMartin S Tallman
Feb 18, 2016·British Journal of Cancer·Thomas A WernerAndreas Krieg

❮ Previous
Next ❯

Citations

Feb 9, 2021·Clinical Colorectal Cancer·Benjamin E UeberrothM Bassam Sonbol
May 18, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Julien HadouxRomain Desgrippes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis